Curcumin-Loaded Niosomes Downregulate mRNA Expression of Pro-Inflammatory Markers Involved in Asthma: An In Vitro Study

Title
Curcumin-Loaded Niosomes Downregulate mRNA Expression of Pro-Inflammatory Markers Involved in Asthma: An In Vitro Study
Publication Date
2020
Author(s)
Wong, Jin-Ying
Yin Ng, Zhao
Mehta, Meenu
Dhar Shukla, Shakti
Panneerselvam, Jithendra
Madheswaran, Thiagarajan
Gupta, Gaurav
Negi, Poonam
Kumar, Pradeep
Pillay, Viness
Hsu, Alan
Hansbro, Nicole G
Wark, Peter
Bebawy, Mary
( author )
OrcID: https://orcid.org/0000-0003-2606-921X
Email: mbebawy@une.edu.au
UNE Id une-id:mbebawy
Hansbro, Philip Michael
Dua, Kamal
Kumar Chellappan, Dinesh
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
Future Medicine Ltd
Place of publication
United Kingdom
DOI
10.2217/nnm-2020-0260
UNE publication id
une:1959.11/61227
Abstract

Aim: In this study, curcumin was encapsulated in niosomes (Nio-Curc) to increase its effectiveness for the treatment of asthma. Materials & methods: The formulation underwent various physicochemical characterization experiments, an in vitro release study, molecular simulations and was evaluated for in vitro anti-inflammatory activity. Results: Results showed that Nio-Curc had a mean particle size of 284.93 ± 14.27 nm, zeta potential of -46.93 and encapsulation efficacy of 99.62%, which demonstrates optimized physicochemical characteristics. Curcumin release in vitro could be sustained for up to 24 h. Additionally, Nio-Curc effectively reduced mRNA transcript expression of pro-inflammatory markers; IL-6, IL-8, IL-1β and TNF-α in immortalized human airway basal cell line (BCi-NS1.1). Conclusion: In this study, we have demonstrated that Nio-Curc mitigated the mRNA expression of pro-inflammatory markers in an in vitro study, which could be applied to treatment of asthma with further studies.

Link
Citation
Nanomedicine, 15(30), p. 2955-2970
ISSN
1748-6963
1743-5889
Start page
2955
End page
2970

Files:

NameSizeformatDescriptionLink